Baker Bros. Advisors LP Marker Therapeutics, Inc. Transaction History

Baker Bros. Advisors LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$1.5 - $2.2 $360,757 - $529,111	-240,505 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$1.69 - $2.79 $2.08 Million - $3.43 Million	-1,229,693 Reduced 83.64%	240,505 $498,000
Q1 2020 May 15, 2020	SELL	$1.59 - $3.35 $47,385 - $99,836	-29,802 Reduced 1.99%	1,470,198 $2.79 Million
Q4 2018 Feb 13, 2019	BUY	$4.2 - $9.74 $6.3 Million - $14.6 Million	1,500,000 New	1,500,000 $8.33 Million

475K

Ticker MRKR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,599,200
Market Cap $236M
Description
Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications in the United States. Its MultiTAA-specific T cell technology is based on the manufact...

Get notified when there are updates to the investment portfolio of Baker Bros. Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Baker Bros. Advisors LP with notifications on news.